Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope - PubMed (original) (raw)
- PMID: 2439915
- DOI: 10.1038/327713a0
Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope
P M Allen et al. Nature. 1987.
Abstract
The precise molecular structure of the antigenic determinant recognized by the T-cell receptor of the CD4-positive cell has not been completely resolved. A major advance in our understanding of this issue has been made by our demonstration of a direct association between an immunogenic peptide and a purified Ia molecule. The most likely and economical hypothesis is that antigen binds directly to an Ia molecule creating the antigenic determinant and that this antigen-Ia complex is recognized by the T-cell receptor. We examined in detail a determinant of hen egg-white lysozyme (HEL) contained in the tryptic fragment HEL(46-61), recognized by T cells in H-2k strains of mice. This peptide binds with a Kd of approximately 3 microM to I-Ak molecules. We have already ascertained that (1) the 10-mer HEL(52-61) is the shortest stimulatory peptide; (2) the Leu56 residue, the only residue different from mouse lysozyme, is responsible for the immunogenicity; (3) the Leu56 and Tyr53 residues are critical for recognition by the T-cell receptor and (4) HEL(46-61) generates multiple determinants when it associated with the I-Ak molecule. If antigen and Ia interact, the antigen must have two features: it must bind to an Ia molecule and also interact with the T-cell receptor. The two sites do not appear to be laterally separable in this peptide and are therefore probably composed of distinct but interspersed amino-acid residues. We have now identified the three residues of HEL(52-61) that contact the T-cell receptor and three other residues that contact the I-Ak molecule. From modelling studies we also propose that HEL(52-61) assumes an alpha-helical conformation as it is bound to I-Ak and recognized by the T-cell receptor.
Similar articles
- Analysis of the interaction of peptide hen egg white lysozyme (34-45) with the I-Ak molecule.
Lambert LE, Unanue ER. Lambert LE, et al. J Immunol. 1989 Aug 1;143(3):802-7. J Immunol. 1989. PMID: 2787347 - Glycopeptides bind MHC molecules and elicit specific T cell responses.
Harding CV, Kihlberg J, Elofsson M, Magnusson G, Unanue ER. Harding CV, et al. J Immunol. 1993 Sep 1;151(5):2419-25. J Immunol. 1993. PMID: 8360471 - T cell inducing determinants contain a hierarchy of residues contacting the T cell receptor.
Evavold BD, Williams SG, Chen JS, Allen PM. Evavold BD, et al. Semin Immunol. 1991 Jul;3(4):225-9. Semin Immunol. 1991. PMID: 1718483 Review. - Use of a receptor competition assay to explore the interaction of the T cell antigen-specific receptor with its ligands.
Ashwell JD, Fox BS, Schwartz RH. Ashwell JD, et al. Fed Proc. 1987 Jan;46(1):183-9. Fed Proc. 1987. PMID: 2433162 Review.
Cited by
- In Silico Immunogenicity Assessment of Therapeutic Peptides.
Li W, Wei J, Jiang Q, Zhou Y, Yan X, Xiang C, Huang J. Li W, et al. Curr Med Chem. 2024;31(26):4100-4110. doi: 10.2174/0109298673264899231206093930. Curr Med Chem. 2024. PMID: 38275064 Review. - Cancer immunotherapy: it's time to better predict patients' response.
Pilard C, Ancion M, Delvenne P, Jerusalem G, Hubert P, Herfs M. Pilard C, et al. Br J Cancer. 2021 Sep;125(7):927-938. doi: 10.1038/s41416-021-01413-x. Epub 2021 Jun 10. Br J Cancer. 2021. PMID: 34112949 Free PMC article. Review. - Evidence of genetic epistasis in autoimmune diabetes susceptibility revealed by mouse congenic sublines.
Collin R, Dugas V, Pelletier AN, Chabot-Roy G, Lesage S. Collin R, et al. Immunogenetics. 2021 Aug;73(4):307-319. doi: 10.1007/s00251-021-01214-9. Epub 2021 Mar 23. Immunogenetics. 2021. PMID: 33755757 - High-Fat Diet Alters Immunogenic Properties of Circulating and Adipose Tissue-Associated Myeloid-Derived CD45+DDR2+ Cells.
Sidles SJ, Xiong Y, Young MRI, LaRue AC. Sidles SJ, et al. Mediators Inflamm. 2019 Feb 28;2019:1648614. doi: 10.1155/2019/1648614. eCollection 2019. Mediators Inflamm. 2019. PMID: 31015794 Free PMC article. - Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors.
Yan L, Liu B. Yan L, et al. Onco Targets Ther. 2018 Dec 24;12:193-204. doi: 10.2147/OTT.S190336. eCollection 2019. Onco Targets Ther. 2018. PMID: 30636882 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous